d
Hi there, I'm here for you : )
Check-in due
ABOUT PAPILIOX
Continuity infrastructure for real-world patient intelligence
PRODUCT
dori creates scalable continuity of care turning patients' needs, questions, check-ins, symptoms, reminders, and visit context into structured signals patients and care teams can act on.

dori
AI health agent that evolves with you.
continuity of care
Patient context, structured over time
24h
between-visit signal
Adaptive AI
adaptive, continuous, and personalized support
Personalized health guidance
Helps patients make sense of symptoms, instructions, next steps, and health questions in context.
Proactive check-ins and reminders
Supports follow-through with timely prompts that adapt to the patient’s real-world care journey.
Visit preparation and recall
Organizes questions before appointments and helps patients remember guidance after they leave.
Longitudinal health insights
Transforms everyday patient interactions into structured signals across time, not isolated moments.

DEMO
See dori in action.
A short product walkthrough of the dori iOS experience.
TEAM
Built by clinicians, scientists, and AI builders.
David Juhn, DDS., MS.
Co-Founder & CEO
Business & Scale: Successfully built and scaled a multimillion-dollar dentistry business.
Clinical Operations: Expert healthcare operator specializing deeply in clinical dentistry.
Biotech Integration: Possesses integral, cross-functional expertise bridging biotechnology and clinical applications.
Michelle Wang, PharmD., PhD.
Co-Founder & CTO
Academic & Regulatory Leadership: Former UCSF Assistant Professor and FDA Interdisciplinary Scientist; raised and executed multimillion-dollar research funds at UCSF.
AI & Real-World Data (RWD): Built advanced AI models utilizing large-scale data from over 5 million patients.
IP & Innovation: Invented 3 UCSF-disclosed technologies and holds 1 provisional patent for an agentic AI system.
Core Expertise: Deep cross-functional knowledge across AI, clinical informatics, clinical pharmacy, drug development, and regulatory sciences.
For partnerships, investor inquiries, or early access, contact us.